Clinical Trials
10 trialsNCT00004070 2017-04-20
Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck Cancer
Dana-Farber Cancer Institute
Phase 1/2 Completed
NCT00004893 2016-07-19
Interleukin-12 in Treating Patients With Metastatic or Recurrent Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT00003107 2014-09-10
Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors
Indiana University
Phase 1 Completed
NCT00003339 2014-05-22
Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV Melanoma
University of Southern California
Phase 2 Completed
NCT00031733 2014-05-22
Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma
University of Southern California
Phase 2 Completed
NCT00015977 2014-03-07
Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
University of Chicago
Phase 2 Completed
NCT00002952 2013-09-05
Vaccine Therapy and Interleukin-12 in Treating Patients With Metastatic Melanoma
University of Chicago
Phase 1/2 Completed
NCT00899821 2012-11-09
Microsphere-Delivered Cytokines in Increasing Tumor Response in Lymphocytes From Patients With Head and Neck Cancer
NYU Langone Health
Phase NA Completed
NCT00003046 2012-07-30
Interleukin-12 in Treating Patients With Cancer in the Abdomen
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00004260 2011-08-03
Interleukin-12 Plus Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
Mayo Clinic
Phase 1 Completed